Trastuzumab deruxtecan [1826843-81-5]

TargetMol Chemicals

Trastuzumab deruxtecan

10

1826843-81-5

Chemical

Research Use Only

Trastuzumab deruxtecan

SEC-HPLC:98.49%

Approximately 45.42 kDa

Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.

3 years

-20°C

12352203